Haladhar Dev Sarma

Haladhar Dev Sarma


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2006 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
PPPallab Pradhan
Pallab Pradhan
JGJyotsnendu Giri
Jyotsnendu Giri
GSGopal Samanta
Gopal Samanta
HSHaladhar Dev Sarma
Haladhar Dev Sarma
KMKaushala Prasad Mishra
Kaushala Prasad Mishra
Dhirendra BahadurDhirendra Bahadur
Dhirendra Bahadur

1 May 1997 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JKJ.P. Kamat
J.P. Kamat
HSHaladhar Dev Sarma
Haladhar Dev Sarma
TDT.P.A. Devasagayam
T.P.A. Devasagayam
KNK. Nesaretnam
K. Nesaretnam
YBY. Basiron
Y. Basiron

1 September 2008 in Applied Radiation and Isotopes
Verified
Journal Article
Closed access
SCSudipta Chakraborty
Sudipta Chakraborty
TDTapas Das
Tapas Das
HSHaladhar Dev Sarma
Haladhar Dev Sarma
MVMeera Venkatesh
Meera Venkatesh
SBSharmila Banerjee
Sharmila Banerjee

1 August 2002 in Applied Radiation and Isotopes
Verified
Journal Article
Closed access
TDTapas Das
Tapas Das
SCSudipta Chakraborty
Sudipta Chakraborty
PUP.R Unni
P.R Unni
SBSharmila Banerjee
Sharmila Banerjee
GSGrace Samuel
Grace Samuel
MPM.R.A Pillai
M.R.A Pillai

1 July 2008 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
SCSudipta Chakraborty
Sudipta Chakraborty
TDTapas Das
Tapas Das
HSHaladhar Dev Sarma
Haladhar Dev Sarma
MVMeera Venkatesh
Meera Venkatesh
SBSharmila Banerjee
Sharmila Banerjee

1 January 2002 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
SCS. Chakraborty
S. Chakraborty
TDT. DAS
T. DAS
PUP. R. Unni
P. R. Unni
HSHaladhar Dev Sarma
Haladhar Dev Sarma
GSG. Samuel
G. Samuel
MPM. R.A. Pillai
M. R.A. Pillai
Polyphosphonate ligands labelled with radioisotopes decaying by moderate energy beta emission have shown utility as palliative agents for painful bone metastasis. 177Lu (T ½ = 6.71 d, E βmax = 497 keV) has radionuclidic properties suitable for use in palliative therapy of bone metastasis. 177Lu was produced at a high specific activity and excellent radionuclidic purity by thermal neutron bombardment of a target prepared from natural Lu. Three polyaminomethylene phosphonate ligands, abbreviated as EDTMP, DTPMP and TTHMP, were synthesized and radiolabelled with 177Lu. Complexation parameters were optimized to achieve maximum yields (97-99.5%). All the complexes were found to retain their stability at room temperature even 14 days after preparation. Biodistribution studies of the complexes were carried out in Wistar rats. All the complexes showed significant bone uptake (6-6.5%/g in tibia at 3 h post-injection (p.i.)) with rapid clearance from blood and minimum uptake in soft tissues. These studies reveal that 177Lu complexes with the synthesized ligands have a potential use in palliative treatment of painful bone metastasis.